Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

GHRP-6: Dosage, Benefits, FDA Status & Clinics (2026)

GHRP-6 FDA status: Research. Growth hormone-releasing peptide that stimulates appetite and GH secretion. See dosage, benefits, side effects, costs, and clinics

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

What Is GHRP-6?

GHRP-6 is a six-amino-acid synthetic peptide that triggers your pituitary gland to release a pulse of growth hormone — and it does it through a receptor system that wasn't even understood when the peptide was first synthesized. That receptor, now called the ghrelin receptor (GHS-R1a), turned out to be the same one that the hunger hormone ghrelin binds to, which explains why GHRP-6's most noticeable side effect is a powerful appetite spike within 20–30 minutes of injection.

It's one of the oldest growth hormone secretagogues still actively studied. Researchers have used it as a diagnostic tool to test pituitary GH reserve, as a research probe to understand the ghrelin axis, and more recently as a starting point for novel therapeutic applications including organ protection and tissue repair. None of those applications are FDA-approved. GHRP-6 is a research compound, full stop.

If you're here because you're considering it for GH optimization, you need to understand both what the research actually shows and what it doesn't — because the gap between the two is significant.

GHRP-6 stimulates growth hormone release by binding ghrelin receptors (GHS-R1a) in the pituitary and hypothalamus — a dual-site mechanism that distinguishes it from GHRH analogs.

Connected topics

Follow this recovery question